Reneo Pharmaceuticals Inc... (RPHM)

AI Score

Unlock

18.20

16.47 (952.02%)

At close: Oct 04, 2024, 8:00 PM

Reneo Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	35.97M	20.38M	27.63M	11.74M	9.08M	30.39M	19.93M	62.13M	118.26M	121.09M	124.66M	126.41M	140.37M	91.22M	53.61M	-24.89M
Short-Term Investments	40.7M	62.46M	75.33M	113.88M	133.6M	63.39M	81.25M	53.95M	8.59M	17.57M	23.01M	31.32M	26.96M	n/a	n/a	49.77M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	153K	64K	81K	81K	79K	81K	84K	79K	78K	78K	78K	78K	78K	1.68M	127K	-24.89M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.32M	1.09M	3.66M	3.16M	3.64M	3.23M	5.18M	4.92M	5.16M	4.05M	6.06M	4.93M	3.81M	2.34M	n/a	n/a
Total Current Assets	77.99M	83.93M	106.62M	128.77M	146.32M	97.02M	106.35M	121M	132.01M	142.72M	153.73M	162.66M	171.14M	93.56M	55.02M	24.89M
Property-Plant & Equipment	574K	648K	733K	1.53M	1.64M	1.77M	1.75M	1.43M	1.52M	1.62M	212K	200K	85K	81K	69K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	727K	712K	814K	1.62M	1.72M	1.85M	1.83M	1.51M	1.6M	1.7M	290K	278K	163K	1.76M	196K	-24.89M
Total Assets	78.72M	84.64M	107.44M	130.39M	148.04M	98.87M	108.18M	122.5M	133.61M	144.41M	154.02M	162.94M	171.3M	95.32M	55.22M	n/a
Account Payables	64K	676K	8.72M	2.47M	1.83M	1.8M	1.89M	2.19M	1.56M	1.57M	2.02M	1.27M	434K	556K	908K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-408K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	331K	331K	331K	325K	318K	363K	n/a	410K	408K	457K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	55K	839K	3.62M	3.5M	2.21M	1.39M	n/a	1.88M	1.37M	761K	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	1.35M	2.81M	18.18M	13.56M	13.74M	10.48M	7.12M	9.45M	8.34M	7.91M	6.2M	6.35M	3.34M	3.93M	4.58M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	8K	7K	7K	1.07M	876K	324K	29K	66K	55K	57K	611K	382K	417K	140.11M	92.76M	n/a
Total Long-Term Liabilities	500K	583K	649K	1.88M	1.77M	1.3M	1.09M	1.01M	1.12M	1.18M	611K	382K	417K	140.11M	92.76M	n/a
Total Liabilities	1.85M	3.4M	18.83M	15.44M	15.51M	11.78M	8.21M	10.46M	9.45M	9.09M	6.81M	6.74M	3.75M	144.04M	97.34M	n/a
Total Debt	823K	907K	973K	1.14M	1.22M	1.34M	1.46M	1.35M	1.47M	1.58M	n/a	n/a	n/a	140.08M	n/a	n/a
Common Stock	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	n/a	n/a	n/a
Retained Earnings	-232.26M	-226.9M	-218.47M	-190.52M	-171.32M	-151.79M	-136.68M	-123.08M	-110.08M	-97.76M	-84.73M	-74.12M	-61.39M	-52.17M	-44.96M	n/a
Comprehensive Income	-13K	-12K	8K	-21K	-31K	12K	-43K	-26K	168K	64K	34K	17K	5K	n/a	n/a	-23.13M
Shareholders Equity	76.87M	81.24M	88.61M	114.94M	132.53M	87.08M	99.97M	112.05M	124.16M	135.32M	147.21M	156.21M	167.55M	-48.72M	-42.12M	22.52M
Total Investments	40.7M	62.46M	75.33M	113.88M	133.6M	63.39M	81.25M	53.95M	8.59M	17.57M	23.01M	31.32M	26.96M	n/a	n/a	49.77M